Glucocorticoids and Apoptosis of Cerebellar Neural Progenitor Cells
糖皮质激素与小脑神经祖细胞的凋亡
基本信息
- 批准号:7240306
- 负责人:
- 金额:$ 7.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-10 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:11-beta-Hydroxysteroid DehydrogenasesAdrenal Cortex HormonesAdultApoptosisBehaviorBetamethasoneBiologyBirthBrainCellsCerebellumCessation of lifeChronic lung diseaseClinical TrialsConceptionsCorticosteroneCytoplasmic GranulesDailyDataDevelopmentDevelopmental Delay DisordersDexamethasoneDoseEnzymesFetal LungFutureGABA AgentsGlucocorticoid ReceptorGlucocorticoidsHumanHydroxysteroid DehydrogenasesImpairmentInfantInterneuronsLong-Term EffectsMediator of activation proteinMothersMotorMotor SkillsN-MethylaspartateNeuraxisNeuronsNumbersPharmaceutical PreparationsPregnancyPremature InfantPrincipal InvestigatorPropertyRelative (related person)Request for ApplicationsRiskRodentSafetySignal TransductionSolventsStructure of molecular layer of cerebellar cortexToxic effectWeekWorkbasedaydevelopmental neurobiologyfollow-upgranule cellimprovedinsightkillingsnerve stem cellneurodevelopmentneurogenesisneurotoxicpostnatalpreventvisual-motor integration
项目摘要
DESCRIPTION (provided by applicant): This application requests support for studies pertaining to the principal investigator's recent finding that glucocorticoids (e.g., dexamethasone) trigger apoptosis in neural progenitor cells (NPCs) in the external granule layer of the cerebellum. Glucocorticoids induce the death of cerebellar NPCs only during a brief period when these cells are dividing and subdividing in order to produce neurons that will subsequently become granule cells in the internal granule layer and, possibly, interneurons in the molecular layer. In rodents this period occurs between postnatal days 4-10. In humans the corresponding period would last from the 20th week to the 45th week post conception. After cerebellar neurogenesis has been accomplished, the NPCs are removed by apoptosis. The signal that these NPCs use to decide when to begin to kill themselves by apoptosis is unknown. Determining what the signal might be has important implications for developmental neurobiology. The fact that 11¿-hydroxysteroid dehydrogenase type 2, an enzyme that breaks down only endogenous glucocorticoids, disappears from the external granule layer of the cerebellum at the end of neurogenesis period, when NPCs undergo apoptosis, suggests that endogenous glucocorticoids might be the natural signal. Clinically, exogenous glucocorticoids (e.g., dexamethasone, betamethasone) are given to mothers, who are at high risk of giving birth prior to 32 weeks gestation, in order to induce maturation of the fetal lungs. In addition postnatal premature infants receive corticosteroids for 2-42 days either to prevent or treat chronic lung disease. Follow-up data from clinical trials suggest that infants exposed to glucocorticoids in addition to having developmental delays and smaller brains and bodies, have impairments in motor skills, motor coordination, and visualmotor integration. These data have raised concern about the relative safety of glucocorticoid exposure in the human infants. The histological work proposed in Specific Aim 1 of this application seeks to determine that glucocorticoids produce apoptosis by activating glucocorticoid receptors and that endogenous glucocorticoids are less likely to produce this toxicity than synthetic ones. Then the long-term effect of a single dose of glucocorticoids on cerebellar neuronal numbers and on motor and coordination tasks will be studied in Specific Aim 2. Results of the proposed studies could provide immediate guidance on which glucocorticoids might be less toxic in humans. In addition the findings will serve as a basis for conducting future studies aimed at more fully understanding the basic biology underlying decisions about when cells undergo apoptosis, and on finding treatments that might be more effective in preventing this drug-induced apoptosis.
描述(由应用程序提供):本应用要求支持与主要研究者最近的发现有关的研究,即糖皮质激素(例如,地塞米松)在小脑外颗粒层中神经元祖细胞(NPC)中触发了神经元祖细胞(NPC)的凋亡。糖皮质激素只有在这些细胞分裂和细分的短时间内诱导小脑NPC的死亡,以产生随后成为内部颗粒层中的颗粒细胞的神经元,并且可能在分子层中的中间神经元。在啮齿动物中,这一时期发生在产后第4-10天之间。在人类中,相应的时期将持续到第20周到概念后第45周。小脑神经发生后,通过凋亡去除NPC。这些NPC用来决定何时开始因细胞凋亡而自杀的信号尚不清楚。确定可能是什么信号对发育神经生物学具有重要意义。 11? - 羟基甾体脱氢酶2型(仅分解的酶,仅内源性糖皮质激素,在神经发生期结束时小脑的外部颗粒层中消失,当NPCS发生凋亡时,这表明内源性glucoticoid可能是天然的。在临床上,为母亲提供了外源性糖皮质激素(例如,地塞米松,替他米松),为了诱导胎儿肺部的成熟,母亲有高风险,即在32周妊娠之前出生。另外,产后早产婴儿会接受2-42天的皮质类固醇,以预防或治疗慢性肺部疾病。来自临床试验的后续数据表明,除了发育延迟,大脑和身体较小的婴儿外,还暴露于糖皮质激素的婴儿,运动技能,运动协调和视觉速度积分的障碍。这些数据引起了人们对糖皮质激素暴露在人类婴儿中的相对安全性的关注。本应用的特定目的1中提出的组织学工作旨在确定糖皮质激素通过激活糖皮质激素受体产生凋亡,而内源性糖皮质激素比合成糖脂产生这种毒性的可能性较小。然后,单剂量的糖皮质激素对小脑神经元数以及运动和协调任务的长期影响将在特定的目标2中进行研究。拟议的研究的结果可以提供有关糖皮质激素在人类中可能毒性较小的立即指导。此外,这些发现将作为进行未来研究的基础,旨在更充分了解有关细胞凋亡何时凋亡的基本生物学的基本生物学,以及寻找可能在防止这种药物诱导的凋亡方面更有效的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NURI B FARBER其他文献
NURI B FARBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NURI B FARBER', 18)}}的其他基金
Washington University Psychiatry Residency Research Education Program
华盛顿大学精神病学住院医师研究教育计划
- 批准号:
9895865 - 财政年份:2018
- 资助金额:
$ 7.6万 - 项目类别:
Washington University Psychiatry Residency Research Education Program
华盛顿大学精神病学住院医师研究教育计划
- 批准号:
10619244 - 财政年份:2018
- 资助金额:
$ 7.6万 - 项目类别:
Washington University Psychiatry Residency Research Education Program
华盛顿大学精神病学住院医师研究教育计划
- 批准号:
10083765 - 财政年份:2018
- 资助金额:
$ 7.6万 - 项目类别:
Washington University Psychiatry Residency Research Education Program
华盛顿大学精神病学住院医师研究教育计划
- 批准号:
10334468 - 财政年份:2018
- 资助金额:
$ 7.6万 - 项目类别:
QUANTITATION OF DMSO BY GC/EI/MS IN MAMMALIAN CNS
通过 GC/EI/MS 对哺乳动物中枢神经系统中的 DMSO 进行定量
- 批准号:
7721555 - 财政年份:2008
- 资助金额:
$ 7.6万 - 项目类别:
相似国自然基金
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
- 批准号:82370796
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:32200798
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:82103851
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
INSM1在静默性促肾上腺皮质激素细胞腺瘤发生发展中的调控机制及潜在靶向治疗研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Hormonal Contraceptives and Adolescent Brain Development
激素避孕药和青少年大脑发育
- 批准号:
10668018 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
Toward therapeutic targeting of liquid-liquid phase separation dynamics in skin
皮肤液-液相分离动力学的治疗靶向
- 批准号:
10679610 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
Avoiding Cesarean-induced Obesity Through Hormone Rescue
通过激素拯救避免剖腹产引起的肥胖
- 批准号:
10628889 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别:
Harnessing single cell RNA sequencing and integrative bioinformatics to identify precision therapeutics for dermatomyositis
利用单细胞 RNA 测序和综合生物信息学确定皮肌炎的精准治疗方法
- 批准号:
10573015 - 财政年份:2023
- 资助金额:
$ 7.6万 - 项目类别: